Login

Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell. 00:10:00

Share On Facebook Share On Twitter

Martin J Schroeter is Chairman/CEO at Kyndryl Holdings Inc. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Unlocking Roth IRA Benefits with Backdoor Contributions
00:10:00
Delta Resources Limited's Delta-1 Gold Project | ANDRÉ TESSIER , President & CEO at Delta Resources Limited
00:10:00
Investment thesis at Green Egg Ventures|Alex Ferber,Co-Founder & Partner,Green Egg Ventures
00:10:00
Wilson Romanini on Navigating Challenges and Innovations in the Fertilizer Industry | Wilson Romanini, CEO, Vittia Fertilizantes e Biológicos SA.
00:00:00
Nipunie S. Rajapakse, M.D., M.P.H.
00:10:00
PT M Cash Integrasi Tbk (MCAS) plans to enter the digital restaurant service business, having begun trials since the beginning of the year.
00:10:00
Empowering Investors: United Commercial Bank PLC Launches Exclusive Loyalty Program
00:10:00
Built by ex-founders and ex-colleagues that helped grow Yelp from a team of 10-5000|Wendy Lim,General Partner,Burst Capital
00:10:00
Golden Cariboo Resources: A Potential Investment in Historic Area that Could Pay Off | Frank Callaghan, President and CEO, Golden Cariboo Resources Ltd. (IE)
00:10:00
checks and makes decisions quickly|Julian Shapiro,Partner,Julian Capital
00:10:00
MOORS & CABOT | Celebrating 125 Years
00:10:00
Chris Heckert of Generational Capital Markets discusses strategic mergers and acquisitions, focusing on valuation and deal execution on MandA.TV.

© 2026 Nehu